Abstract
The treatment of Duchenne Muscular Dystrophy (DMD) is palliative and aims to minimize dysfunctions and promote the quality of life of patients and their families. From the point of view of palliative care, which is indicated since the diagnosis of the disease, the evaluation of symptoms is essential to allow adequate therapeutic management. The Edmonton Symptom Assessment System (ESAS) is…